Scemblix Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
How Supplied
Manufacturer
Generic Availability
Mechanism of Action
Scemblix Indications
Indications
Scemblix Dosage and Administration
Adult
Children
Scemblix Contraindications
Not Applicable
Scemblix Boxed Warnings
Not Applicable
Scemblix Warnings/Precautions
Warnings/Precautions
Scemblix Pharmacokinetics
Absorption
Median Tmax of asciminib: 2.5 hours (range: 2–3 hours).
Distribution
Plasma protein bound: 97%.
Apprarent volume of distribution at steady state: 151 L.
Elimination
Scemblix Interactions
Interactions
Scemblix Adverse Reactions
Adverse Reactions
Upper respiratory tract infections, musculoskeletal pain, headache, fatigue, nausea, rash, diarrhea, lab abnormalities (decreased platelet count, decreased neutrophil count, decreased hemoglobin, decreased lymphocyte count, increased triglycerides, increased creatine kinase, increased ALT/AST, increased lipase, increased amylase, increased uric acid); hypertension, myelosuppression, pancreatic, or cardiovascular toxicity.
Scemblix Clinical Trials
See Literature
Scemblix Note
Not Applicable
Scemblix Patient Counseling
See Literature
Images
